Guangdong Zhongsheng Pharmaceutical Invests USD7.25 Million to Found Ophthalmology Subsidiary

Guangdong Zhongsheng Pharmaceutical Invests USD7.25 Million to Found Ophthalmology Subsidiary

Yicai Global

Date: Fri, 03/24/2017 - 23:14 / source:Yicai
Guangdong Zhongsheng Pharmaceutical Invests USD7.25 Million to Found Ophthalmology Subsidiary
Guangdong Zhongsheng Pharmaceutical Invests USD7.25 Million to Found Ophthalmology Subsidiary

(Yicai Global) Dec. 15 -- Guangdong Zhongsheng Pharmaceutical Co. [SHE:002317] will invest CNY50 million (USD7.25 million) to set up an investment management company to seek investment opportunities in the field of ophthalmic medicine, medical services and health care.

The company said yesterday it will spend CNY50 million of its own to form a wholly-owned subsidiary -- Guangdong Qianjing Ophthalmology Investment Management Co.

The subsidiary's strategic goal is to develop an industry combining medicine with medical services and health care management, with ophthalmological ecology as its core business segment, and constitute a team of eye specialists to provide quality services to patients and ophthalmologists, the company said. This move will help the firm establish a presence in the field of ophthalmology.

Follow Yicai Global on

Keywords: